NVAX logo

Novavax (NVAX) Working Capital

Annual Working Capital

-$491.25 M
+$265.30 M+35.07%

December 31, 2023


Summary


Performance

NVAX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Quarterly Working Capital

-$77.32 M
-$122.88 M-269.71%

September 30, 2024


Summary


Performance

NVAX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

NVAX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.1%+83.3%
3 y3 years-173.5%+67.1%
5 y5 years-766.2%-132.7%

NVAX Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-108.9%+35.1%-184.0%+91.8%
5 y5-year-173.5%+35.1%-107.5%+91.8%
alltimeall time-173.5%+35.1%-107.5%+91.8%

Novavax Working Capital History

DateAnnualQuarterly
Sep 2024
-
-$77.32 M(-269.7%)
Jun 2024
-
$45.56 M(-159.0%)
Mar 2024
-
-$77.26 M(-84.3%)
Dec 2023
-$491.25 M(-35.1%)
-$491.25 M(+6.4%)
Sep 2023
-
-$461.83 M(-1.5%)
Jun 2023
-
-$468.70 M(-50.6%)
Mar 2023
-
-$947.83 M(+25.3%)
Dec 2022
-$756.55 M(+221.7%)
-$756.55 M(-922.3%)
Sep 2022
-
$92.00 M(-554.6%)
Jun 2022
-
-$20.24 M(-123.4%)
Mar 2022
-
$86.40 M(-136.7%)
Dec 2021
-$235.20 M(-135.2%)
-$235.20 M(-155.9%)
Sep 2021
-
$420.77 M(-40.2%)
Jun 2021
-
$703.48 M(-32.2%)
Mar 2021
-
$1.04 B(+55.3%)
Dec 2020
$668.53 M(+835.6%)
$668.53 M(+54.8%)
Sep 2020
-
$432.00 M(+2.1%)
Jun 2020
-
$423.05 M(+79.1%)
Mar 2020
-
$236.25 M(+230.6%)
Dec 2019
$71.45 M(-3.1%)
$71.45 M(+5.9%)
Sep 2019
-
$67.45 M(-1.9%)
Jun 2019
-
$68.73 M(-25.2%)
Mar 2019
-
$91.90 M(+24.6%)
Dec 2018
$73.74 M(-43.1%)
$73.74 M(-35.2%)
Sep 2018
-
$113.83 M(-24.8%)
Jun 2018
-
$151.32 M(+11.2%)
Mar 2018
-
$136.13 M(+5.0%)
Dec 2017
$129.64 M(-41.5%)
$129.64 M(-17.8%)
Sep 2017
-
$157.72 M(-7.2%)
Jun 2017
-
$169.89 M(-15.9%)
Mar 2017
-
$201.95 M(-8.8%)
Dec 2016
$221.42 M(+5.1%)
$221.42 M(-20.4%)
Sep 2016
-
$278.22 M(-17.7%)
Jun 2016
-
$338.10 M(-18.2%)
Mar 2016
-
$413.54 M(+96.2%)
Dec 2015
$210.76 M(+36.8%)
$210.76 M(-26.1%)
Sep 2015
-
$285.23 M(-6.8%)
Jun 2015
-
$305.93 M(-4.8%)
Mar 2015
-
$321.32 M(+108.6%)
Dec 2014
$154.04 M(+21.4%)
$154.04 M(-11.1%)
Sep 2014
-
$173.34 M(+16.2%)
Jun 2014
-
$149.12 M(+29.5%)
Mar 2014
-
$115.16 M(-9.2%)
Dec 2013
$126.88 M(+227.6%)
$126.88 M(-9.9%)
Sep 2013
-
$140.76 M(+312.7%)
Jun 2013
-
$34.11 M(-19.7%)
Mar 2013
-
$42.47 M(+9.6%)
Dec 2012
$38.73 M(+109.0%)
$38.73 M(+48.7%)
Sep 2012
-
$26.04 M(+1.9%)
Jun 2012
-
$25.56 M(+37.4%)
Mar 2012
-
$18.60 M(+0.4%)
Dec 2011
$18.53 M(-19.7%)
$18.53 M(-5.0%)
Sep 2011
-
$19.51 M(+0.5%)
Jun 2011
-
$19.42 M(+8.8%)
Mar 2011
-
$17.85 M(-22.6%)
Dec 2010
$23.07 M
$23.07 M(-18.4%)
Sep 2010
-
$28.28 M(+48.3%)
DateAnnualQuarterly
Jun 2010
-
$19.07 M(-22.4%)
Mar 2010
-
$24.58 M(-32.6%)
Dec 2009
$36.48 M(+394.3%)
$36.48 M(+24.5%)
Sep 2009
-
$29.29 M(+34.0%)
Jun 2009
-
$21.85 M(<-9900.0%)
Mar 2009
-
-$190.00 K(-102.6%)
Dec 2008
$7.38 M(-82.8%)
$7.38 M(-55.3%)
Sep 2008
-
$16.50 M(-43.7%)
Jun 2008
-
$29.28 M(-15.6%)
Mar 2008
-
$34.71 M(-18.9%)
Dec 2007
$42.81 M(-40.5%)
$42.81 M(-13.9%)
Sep 2007
-
$49.70 M(-14.1%)
Jun 2007
-
$57.84 M(-11.6%)
Mar 2007
-
$65.39 M(-9.2%)
Dec 2006
$72.00 M(+120.0%)
$72.00 M(-5.9%)
Sep 2006
-
$76.48 M(-4.9%)
Jun 2006
-
$80.46 M(-6.3%)
Mar 2006
-
$85.91 M(+162.4%)
Dec 2005
$32.73 M(+113.1%)
$32.73 M(+445.9%)
Sep 2005
-
$6.00 M(+124.3%)
Jun 2005
-
$2.67 M(-64.1%)
Mar 2005
-
$7.44 M(-51.5%)
Dec 2004
$15.36 M(-43.6%)
$15.36 M(-37.6%)
Sep 2004
-
$24.61 M(+70.2%)
Jun 2004
-
$14.47 M(-33.8%)
Mar 2004
-
$21.84 M(-19.8%)
Dec 2003
$27.23 M(+7102.6%)
$27.23 M(+444.7%)
Sep 2003
-
$5.00 M(-42.2%)
Jun 2003
-
$8.65 M(-28.9%)
Mar 2003
-
$12.16 M(+3118.3%)
Dec 2002
$378.00 K(-97.9%)
$378.00 K(-92.8%)
Sep 2002
-
$5.23 M(-62.6%)
Jun 2002
-
$13.99 M(+39.1%)
Mar 2002
-
$10.05 M(-44.2%)
Dec 2001
$18.03 M(+46.2%)
$18.03 M(-16.6%)
Sep 2001
-
$21.63 M(+111.2%)
Jun 2001
-
$10.24 M(+29.6%)
Mar 2001
-
$7.90 M(-35.9%)
Dec 2000
$12.33 M(-2566.2%)
$12.33 M(+42.1%)
Sep 2000
-
$8.68 M(-23.1%)
Jun 2000
-
$11.28 M(-20.1%)
Mar 2000
-
$14.11 M(-2922.4%)
Dec 1999
-$500.00 K(-266.7%)
-$500.00 K(-350.0%)
Sep 1999
-
$200.00 K(-92.6%)
Jun 1999
-
$2.70 M(-640.0%)
Mar 1999
-
-$500.00 K(-266.7%)
Dec 1998
$300.00 K(-92.5%)
$300.00 K(-95.8%)
Sep 1998
-
$7.20 M(-12.2%)
Jun 1998
-
$8.20 M(-10.9%)
Mar 1998
-
$9.20 M(+130.0%)
Dec 1997
$4.00 M(+53.8%)
$4.00 M(-14.9%)
Sep 1997
-
$4.70 M(-16.1%)
Jun 1997
-
$5.60 M(-13.8%)
Mar 1997
-
$6.50 M(+150.0%)
Dec 1996
$2.60 M
$2.60 M(+36.8%)
Sep 1996
-
$1.90 M(-26.9%)
Jun 1996
-
$2.60 M(-23.5%)
Mar 1996
-
$3.40 M

FAQ

  • What is Novavax annual working capital?
  • What is the all time high annual working capital for Novavax?
  • What is Novavax annual working capital year-on-year change?
  • What is Novavax quarterly working capital?
  • What is the all time high quarterly working capital for Novavax?
  • What is Novavax quarterly working capital year-on-year change?

What is Novavax annual working capital?

The current annual working capital of NVAX is -$491.25 M

What is the all time high annual working capital for Novavax?

Novavax all-time high annual working capital is $668.53 M

What is Novavax annual working capital year-on-year change?

Over the past year, NVAX annual working capital has changed by +$265.30 M (+35.07%)

What is Novavax quarterly working capital?

The current quarterly working capital of NVAX is -$77.32 M

What is the all time high quarterly working capital for Novavax?

Novavax all-time high quarterly working capital is $1.04 B

What is Novavax quarterly working capital year-on-year change?

Over the past year, NVAX quarterly working capital has changed by +$384.51 M (+83.26%)